Sofpironium bromide: an investigational agent for the treatment of axillary hyperhidrosis

2021 ◽  
Author(s):  
Stamatios Gregoriou ◽  
Aikaterini Tsiogka ◽  
George Kontochristopoulos ◽  
Annamaria Offidani ◽  
Anna Campanati
Keyword(s):  
Axillary Hyperhidrosis ◽  
Investigational Agent

Patient-Reported Outcomes from Two Randomized, Double-Blind, Vehicle-Controlled Phase 3 Trials in Axillary Hyperhidrosis (ATMOS-1 & ATMOS-2)

2017 ◽  
Vol 1 ◽  
pp. s96
Author(s):  
David M Pariser ◽  
Adelaide A Hebert ◽  
Janice Drew ◽  
John Quiring ◽  
Dee Anna Glaser
Keyword(s):  
Patient Reported Outcomes ◽  
Axillary Hyperhidrosis ◽  
Phase 3 ◽  
Double Blind ◽  
Patient Reported

Abstract Not AvailableDisclosure: Study supported by Dermira.

Open-Label Study (ARIDO) Evaluating Long-Term Safety of Topical Glycopyrronium Tosylate (GT) in Patients with Axillary Hyperhidrosis

2017 ◽  
Vol 1 ◽  
pp. s95 ◽  
Author(s):  
Dee Anna Glaser ◽  
Adelaide A Hebert ◽  
Alexander Nast ◽  
William P Werschler ◽  
Stephen Shideler ◽  
...  
Keyword(s):  
Axillary Hyperhidrosis ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

Abstract Not AvailableDisclosure: Study supported by Dermira.

Confirmatory Psychometric Evaluation of the Axillary Sweating Daily Diary: A Vaildated Patient-Reported Outcome Measure to Assess Axillary Hyperhidrosis Sweating Severity

2017 ◽  
Vol 1 ◽  
pp. s94 ◽  
Author(s):  
Dee Anna Glaser ◽  
Adelaide A Hebert ◽  
Sheri Fehnel ◽  
Dana DiBenedetti ◽  
Lauren Nelson ◽  
...  
Keyword(s):  
Outcome Measure ◽  
Daily Diary ◽  
Psychometric Evaluation ◽  
Patient Reported Outcome ◽  
Axillary Hyperhidrosis ◽  
Patient Reported Outcome Measure ◽  
Patient Reported

Abstract Not AvailableDisclosure: Study supported by Dermira.

Patient-Reported Outcomes from Two Randomized, Double-Blind, Vehicle Controlled Phase 3 Trials in Axillary Hyperhidrosis (ATMOS-1 & ATMOS-2)

2018 ◽  
Vol 2 ◽  
pp. S41
Author(s):  
David M Pariser ◽  
Adelaide A Hebert ◽  
Janice Drew ◽  
John Quiring ◽  
Dee Anna Glaser
Keyword(s):  
Patient Reported Outcomes ◽  
Axillary Hyperhidrosis ◽  
Phase 3 ◽  
Double Blind ◽  
Patient Reported

Abstract not available. Disclosures: Study supported by Dermira. Copyright SKIN 2018

Sign in / Sign up

Export Citation Format

Share Document